With COVID-19 test kits in high demand, the FDA has been authorizing new at-home sample collections to help make tests more accessible.
Until this point, all at-home tests have required collection from a patient’s nose using a nasal swab and saline. But, earlier in May, the FDA approved the first COVID-19 saliva-based at home collection test by Rutgers Clinical Genomics Laboratory. This prescription-only test allows patients to collect their own sample, easily and safely, without requiring a trip to the doctor’s office.
Saliva-based testing has been found to be just as accurate, if not more so, than nasal testing and the sample is easier, safer and more comfortable to attain.
Learn more about this at home test kit here.
